Building a New Foundation for Clinical Development with Precision Diagnostics & Molecular Insights 

Advances in molecular diagnostics are redefining how clinical trials are designed and executed. This session will explore how Treatment on Molecular Residual Disease Result (TOMR) can unlock new approaches to development across  disease stages, with a focus on translating MRD insights into actionable clinical strategies. 

• Shape the future of TOMR-driven development through interactive discussion and feedback 
• Explore innovative trial designs and treatment paradigms in early-stage (adjuvant) settings 
• Examine how MRD can accelerate efficacy readouts in late-stage and metastatic programs 
• Workshop near-term clinical opportunities across indications and therapeutic modalities 

Engage in a collaborative session focused on practical application, ideation, and peer exchange with Team Natera.